Technology News and Research

RSS

Retina Implant's microchip restores useful vision in patients blind due to retinitis pigmentosa

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the publication of a peer-reviewed study in Proceedings of the Royal Society B discussing the technical and clinical results obtained during their first human clinical trial.

3 Nov 2010

New Ovation systems improve nucleic acid extraction from FFPE tissue samples

NuGEN Technologies, the provider of innovative RNA and DNA sample preparation solutions for genomic analysis, today announced the availability of the Ovation WGA FFPE System and the Ovation RNA-Seq FFPE System. These are the first commercially available products designed specifically to enable researchers to utilize next-generation sequencing (NGS) technologies to analyze nucleic acids extracted from Formalin-Fixed Paraffin-Embedded (FFPE) tissues.

3 Nov 2010

Strengthening influenza vaccination programs may help states improve coverage against pandemics

Strengthening routine influenza vaccination and health programs may help states improve their vaccination coverage against future pandemics or other health emergencies, a new study suggests.

3 Nov 2010

Eliminating copayments for high-value prescription drugs improves employees' adherence to treatment regimens

An initiative by the U. S. technology company Pitney Bowes to make medications of proven value less expensive for their employees succeeded in stabilizing employees' adherence to their treatment regimens, according to a Commonwealth Fund-supported study published in this month's Health Affairs.

3 Nov 2010

Immense potential for digitized personal health records in chronic disease management

Faster and more widely available internet access has improved our lives in many ways but healthcare is lagging behind, according to researchers writing in the International Journal of Medical Engineering and Informatics.

3 Nov 2010

GlobalNet Services receives $53 million contract from FDA for web support and hosting services

GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that the company was awarded a $53 million contract by the U.S. Food and Drug Administration (FDA) for Web Support and Hosting Services.

3 Nov 2010

Tolerx establishes Scientific Advisory Board to advance type 1 diabetes study

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, announced today that it has established a Scientific Advisory Board to help advance the company's research and clinical studies in type 1 diabetes.

3 Nov 2010

Immunomedics product candidates, technologies receive recognition from QTDP program

Immunomedics, Inc. a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that all 12 applications from the Company were certified by the Internal Revenue Service of the Department of Treasury as qualified investments in accordance with the Qualifying Therapeutic Discovery Project (QTDP) program under section 48D of the Internal Revenue Code. As a result, the Company will receive an aggregate cash award of $2.9 million.

3 Nov 2010

CONRAD receives $5 million award from USAID

CONRAD, leaders in reproductive health and HIV prevention research, today announced a $5 million award from the US Agency for International Development (USAID). The grant will fund research and development of vaginal rings that are contraceptive and also prevent HIV and STI infections.

3 Nov 2010

Quanterix granted $733,437 under QTDP program for Single Molecule Array platform

Quanterix Corporation, a single molecule technology company focused on developing a next generation diagnostics platform, announced today that it was awarded a total of $733,437 in grants under the Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP program recognized Quanterix's Single Molecule Array (SiMoA™) platform as a promising advance that will improve diagnosis and treatment of disease while reducing healthcare costs.

3 Nov 2010

ImmunoGen to present clinical data of lead compounds at EORTC-NCI-AACR Symposium

ImmunoGen, Inc. a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that several ImmunoGen poster presentations will be made at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics to be held in Berlin, Germany, November 16-19, 2010.

3 Nov 2010

Waters launches new program to support scientific innovation

Waters Corporation today launched a new program to support scientific innovation in the fields of health and life science research, sports science, food safety, clinical research and environmental protection.

3 Nov 2010

JenaValve commences CE-Mark study for transapical TAVI system

JenaValve™ Technology, Inc., a medical device company specialized in developing transcatheter valve replacement products, announced today the start of its multicenter CE-mark study. The first two implantations of its transapical TAVI system were performed by Dr. med. Hendrik Treede at the Universitäres Herzzentrum Hamburg.

3 Nov 2010

Illumina, Expression Analysis support Cancer GWAS and Data Analysis Grant program

Expression Analysis today announced that it and Illumina, Inc. are jointly funding a Cancer GWAS (Genome-Wide Association Study) and Data Analysis Grant program to support cutting-edge projects that show promise in identifying genetic elements important to cancer research and treatment.

From Illumina, Inc. 3 Nov 2010

Endologix implants Ventana stent graft for endovascular repair at Auckland City Hospital

Endologix, Inc. developer of minimally invasive treatments for aortic disorders, announced today the first clinical implant of the Company's Ventana fenestrated stent graft at Auckland City Hospital in Auckland, New Zealand.

3 Nov 2010

STAAR Surgical third quarter total net sales increases 6% to $13.2 million

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the third quarter ended October 1, 2010. Revenue for the period grew 6% to $13.2 million reflecting core product (IOLs and ICLs) revenue growth of 10% and a 44% decrease in defocused product revenue as compared to the third quarter of 2009.

3 Nov 2010

Cambrex acquires 51% equity stake in Zenara for $20M

Cambrex Corporation announced today that it acquired a 51% stake in Zenara Pharma, a Hyderabad, India based pharmaceutical company focused on the formulation of final dosage form products.

3 Nov 2010

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

GenMark Diagnostics, Inc. a provider of automated, multiplex molecular diagnostic testing systems, announced today that it has acquired a non-exclusive license to Innogenetics' Hepatitis C Virus (HCV) genotyping patent estate for the United States.

3 Nov 2010

ArthroCare SpeedFix Suture Anchor system granted FDA clearance

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedFix Suture Anchor system (SpeedFix™). SpeedFix, a push-in anchor made of PEEK (polyether-etherketone) polymer, is designed for the repair of certain tears of the labrum in a shoulder.

3 Nov 2010

Health IT: Apps; Competitive contracts; Electronic medical records

The Wall Street Journal: "Indian technology companies are eyeing a coming wave of U.S. spending to digitize health care records. But sensitivity over outsourcing and resistance by American hospitals to sending medical information overseas could thwart efforts to win big contracts." Next year, the U.S. government will dispense billions to "health-care providers who adopt electronic medical records." Doctors are also facing "a federal mandate to upgrade software as the U.S. switches to a new system of insurance billing codes."

3 Nov 2010

Technology News and Research

Retina Implant's microchip restores useful vision in patients blind due to retinitis pigmentosa

New Ovation systems improve nucleic acid extraction from FFPE tissue samples

Strengthening influenza vaccination programs may help states improve coverage against pandemics

Eliminating copayments for high-value prescription drugs improves employees' adherence to treatment regimens

Immense potential for digitized personal health records in chronic disease management

GlobalNet Services receives $53 million contract from FDA for web support and hosting services

Tolerx establishes Scientific Advisory Board to advance type 1 diabetes study

Immunomedics product candidates, technologies receive recognition from QTDP program

CONRAD receives $5 million award from USAID

Quanterix granted $733,437 under QTDP program for Single Molecule Array platform

ImmunoGen to present clinical data of lead compounds at EORTC-NCI-AACR Symposium

Waters launches new program to support scientific innovation

JenaValve commences CE-Mark study for transapical TAVI system

Illumina, Expression Analysis support Cancer GWAS and Data Analysis Grant program

Endologix implants Ventana stent graft for endovascular repair at Auckland City Hospital

STAAR Surgical third quarter total net sales increases 6% to $13.2 million

Cambrex acquires 51% equity stake in Zenara for $20M

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

ArthroCare SpeedFix Suture Anchor system granted FDA clearance

Health IT: Apps; Competitive contracts; Electronic medical records

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News